Researchers at UCLA's Jules Stein Eye Institute and colleagues have successfully used specialized retinal cells derived from human embryonic stem cells to improve the vision of two legally blind patients.
by Walter Jessen, Ph.D. on Tuesday, February 7, 2012
Researchers at UCLA's Jules Stein Eye Institute and colleagues have successfully used specialized retinal cells derived from human embryonic stem cells to improve the vision of two legally blind patients.
Like this article? Highlight HEALTH 2.0 delivers weekly articles on new ideas impacting health and medicine. Join the community by subscribing (more).